Aethlon Medical (AEMD): היקף יתרות המזומנים של החברה

Aethlon Medical (AEMD) is developing an innovative Hemopurifier designed to clear blood of tumor markers and viruses. The cash position reflects liquidity dynamics, where the metric value of 0.01 captures the current balance. Stable demand in critical care medicine renders the business independent of GDP, while a flawless reputation within the scientific community confirms the brand's high level of professionalism.
פילוחי נתונים אנליטיים מרוכזים עבור Aethlon Medical Inc (AEMD)

This metric reflects the total volume of liquid assets available for operational management. By analyzing the company's free cash position, an investor assesses the business's ability to service its obligations without incurring external debt. The metric measures the actual margin of safety, mitigating the risk of bankruptcy during cash flow gaps. For Aethlon Medical (AEMD), this reserve is critical due to the binary risks associated with filter development. Sufficient capital ensures the company's survival until the completion of clinical trials.